Related Experiment Video
Updated: Jul 10, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis
Yide Mei1, Chongwei Xie, Wei Xie
1Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
Abstract:
Although camptothecin (CPT) has been reported to induce apoptosis in various cancer cells, the molecular details of this regulation remain largely unknown. In this study, we demonstrate that BH3-only protein Noxa is upregulated during CPT-induced apoptosis, which is independent of p53. In addition, we show that phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is responsible for Noxa's induction. Luciferase assay and cAMP response element binding protein (CREB) knockdown experiments further demonstrate that CREB is involved in the transcriptional upregulation of Noxa. Moreover, blocking Noxa expression using specific small interfering ribonucleic acid (siRNA) significantly reduces the apoptosis in response to CPT, indicating that Noxa is an essential mediator for CPT-induced apoptosis. Interestingly, antiapoptotic Mcl-1 was also upregulated through PI3K/Akt signaling pathway upon CPT treatment. Using immunoprecipitation assay, Noxa was found to interact with Mcl-1 in the presence or absence of CPT. Knockdown of Mcl-1 expression by short hairpin ribonucleic acid (shRNA) was shown to potentiate CPT-induced apoptosis. Consistently, ectopic overexpression of Mcl-1 rescued cells from apoptosis induced by CPT. Cells coexpressing Noxa and Mcl-1 at different ratio correlates well with the extent of apoptosis, suggesting that the balance between Noxa and Mcl-1 may determine the susceptibility of HeLa cells to CPT-induced apoptosis.
Insights
Camptothecin (CPT) induces apoptosis by upregulating the BH3-only protein Noxa, independent of p53. The balance between Noxa and antiapoptotic Mcl-1 determines cancer cell susceptibility to CPT.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- Camptothecin (CPT) is known to induce apoptosis in cancer cells, but the underlying molecular mechanisms require further elucidation.
- The role of BH3-only proteins in CPT-induced apoptosis is not fully understood.
- Regulation of apoptosis by signaling pathways like PI3K/Akt is crucial in cancer therapy.
Purpose of the Study:
- To investigate the molecular mediators of CPT-induced apoptosis.
- To identify the signaling pathways regulating these mediators.
- To determine the role of Noxa and Mcl-1 in CPT-induced apoptosis and their interplay.
Main Methods:
- Upregulation of Noxa and Mcl-1 was assessed during CPT treatment.
- Phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway involvement was investigated.
- Luciferase assays and cAMP response element binding protein (CREB) knockdown were used to study transcriptional regulation.
- Small interfering ribonucleic acid (siRNA) and short hairpin ribonucleic acid (shRNA) were employed to knock down Noxa and Mcl-1, respectively.
- Immunoprecipitation assays were performed to analyze protein interactions.
- Cell viability assays were conducted to assess apoptosis levels.
Main Results:
- BH3-only protein Noxa is upregulated during CPT-induced apoptosis, independent of p53.
- The PI3K/Akt signaling pathway mediates Noxa induction via CREB transcriptional activity.
- Blocking Noxa expression significantly reduces CPT-induced apoptosis, confirming Noxa as an essential mediator.
- Antiapoptotic Mcl-1 is also upregulated via the PI3K/Akt pathway.
- Noxa interacts with Mcl-1, and Mcl-1 knockdown potentiates CPT-induced apoptosis, while Mcl-1 overexpression confers resistance.
- The ratio of Noxa to Mcl-1 expression correlates with HeLa cell susceptibility to CPT.
Conclusions:
- Noxa is a critical mediator of CPT-induced apoptosis, regulated by the PI3K/Akt/CREB pathway.
- The antiapoptotic protein Mcl-1 counteracts CPT-induced apoptosis by interacting with Noxa.
- The balance between Noxa and Mcl-1 expression levels dictates cancer cell fate upon CPT treatment, highlighting a potential therapeutic target.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
